HUB Investment Partners LLC Reduces Stake in UnitedHealth Group Incorporated (NYSE:UNH)

HUB Investment Partners LLC reduced its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 2.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 36,404 shares of the healthcare conglomerate’s stock after selling 974 shares during the quarter. HUB Investment Partners LLC’s holdings in UnitedHealth Group were worth $18,415,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Wallace Capital Management Inc. raised its holdings in UnitedHealth Group by 0.9% during the third quarter. Wallace Capital Management Inc. now owns 2,119 shares of the healthcare conglomerate’s stock valued at $1,239,000 after acquiring an additional 19 shares during the period. Western Pacific Wealth Management LP grew its position in shares of UnitedHealth Group by 2.2% during the fourth quarter. Western Pacific Wealth Management LP now owns 902 shares of the healthcare conglomerate’s stock valued at $456,000 after purchasing an additional 19 shares in the last quarter. MCF Advisors LLC grew its position in shares of UnitedHealth Group by 0.8% during the fourth quarter. MCF Advisors LLC now owns 2,578 shares of the healthcare conglomerate’s stock valued at $1,304,000 after purchasing an additional 20 shares in the last quarter. Axiom Financial Strategies LLC grew its position in shares of UnitedHealth Group by 3.6% during the fourth quarter. Axiom Financial Strategies LLC now owns 575 shares of the healthcare conglomerate’s stock valued at $291,000 after purchasing an additional 20 shares in the last quarter. Finally, 44 Wealth Management LLC grew its position in shares of UnitedHealth Group by 1.6% during the fourth quarter. 44 Wealth Management LLC now owns 1,309 shares of the healthcare conglomerate’s stock valued at $662,000 after purchasing an additional 21 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $503.05 on Thursday. The firm has a market capitalization of $460.14 billion, a PE ratio of 32.45, a price-to-earnings-growth ratio of 1.37 and a beta of 0.62. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company’s fifty day moving average price is $510.48 and its 200-day moving average price is $548.22.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s revenue was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $5.83 earnings per share. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.67%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on UNH. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Truist Financial dropped their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Piper Sandler dropped their price target on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research report on Thursday, January 2nd. Wells Fargo & Company dropped their price target on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research report on Tuesday, January 28th. Finally, Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.